Subscribe
Subscribe
Subscribe Options (Close)
Topic: life sciences
New with Topic: life sciences
Xconomy posted a blog entry
Arena Loses Merck Collaboration After Clogged-Artery Drug Fails Clinical Trial
Somebody always delivers some bad news on the slow days before Christmas, and this year, it’s Arena Pharmaceuticals. The...
Somebody always delivers some bad news on the slow days before Christmas, and this year, it’s Arena Pharmaceuticals. The...
1 day ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., San Diego, San Diego blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., San Diego, San Diego blog..., BiotechXconomy posted a blog entry
HyperMed Files for Chapter 11 Bankruptcy
Burlington, MA-based medical devices firm HyperMed has filed for Chapter 11 bankruptcy and ceased operations, the Boston...
Burlington, MA-based medical devices firm HyperMed has filed for Chapter 11 bankruptcy and ceased operations, the Boston...
1 day ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston briefs, National..., Life Sciences
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston briefs, National..., Life SciencesXconomy posted a blog entry
pSivida Shares Boom as Eye Drug Passes Pivotal Trial
Shares of pSivida (NASDAQ: PSDV) rocketed more than 50 percent this morning on some positive clinical trial news. The...
Shares of pSivida (NASDAQ: PSDV) rocketed more than 50 percent this morning on some positive clinical trial news. The...
1 day ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., BiotechXconomy posted a blog entry
In Development of Bio-Engineered Skin Tissue, Third Try is Charm for Advanced BioHealing
When it comes to commercializing a bio-engineered human skin substitute that could be used to treat diabetic ulcers and other...
When it comes to commercializing a bio-engineered human skin substitute that could be used to treat diabetic ulcers and other...
Xconomy posted a blog entry
Ambit, Buoyed by Astellas Deal, Attempting Rare Switch from Platform to Drug Developer
Ambit Biosciences made news last Friday when it pulled in $40 million through a partnership with Japan-based Astellas Pharma....
Ambit Biosciences made news last Friday when it pulled in $40 million through a partnership with Japan-based Astellas Pharma....
2 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., San Diego, San Diego blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., San Diego, San Diego blog..., BiotechXconomy posted a blog entry
Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News
New England’s drug developers and device makers are squeezing in a few more partnerships, acquisitions, financings, and...
New England’s drug developers and device makers are squeezing in a few more partnerships, acquisitions, financings, and...
2 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Roundup
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., RoundupXconomy posted a blog entry
The Top Five Disruptive Technologies From the Decade of Genomics
1. The Human Genome Project2. Massively parallel DNA sequencing3. Personalizing therapeutics via companion...
1. The Human Genome Project2. Massively parallel DNA sequencing3. Personalizing therapeutics via companion...
2 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston Xcon, National, National Xcon, San Diego...
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston Xcon, National, National Xcon, San Diego...Xconomy posted a blog entry
AVI Biopharma Drug Shows Hint of Effect Against Muscular Dystrophy In Small Study
Bothell, WA-based AVI Biopharma (NASDAQ: AVII) is trying to develop the first treatment to correct an underlying molecular...
Bothell, WA-based AVI Biopharma (NASDAQ: AVII) is trying to develop the first treatment to correct an underlying molecular...
2 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., BiotechXconomy posted a blog entry
GI Dynamics Gets European Approval
GI Dynamics has garnered European marketing approval for its temporary intestinal implant for treating Type 2 diabetes and...
GI Dynamics has garnered European marketing approval for its temporary intestinal implant for treating Type 2 diabetes and...
2 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston briefs, National..., medical...
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston briefs, National..., medical...Related topics
biotech
boston
Boston blog main
Boston briefs
deals
diabetes
Medical Devices
National blog main
National briefs
obesity
people
Pfizer
SanDiego
San Diego blog main
startups
Top members tagged
Top communities tagged
You
Explore
Create
Help
MyBlogLog Blog | MyBlogLog RSS Feed | Terms of Service | Privacy Policy | Report Abuse
Copyright © 2005-2009 MyBlogLog. All rights reserved. Copyright/IP Policy